Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaoyong Li

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Intravenous Administration of EXG110 Resulted in Substrate Correction in Fabry Mice and Sustained Enzyme Activity in Non-human PrimatesShaoyong Li, Pengfei Yu, Hong Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Challenging the More-Is-Better Dogma: A Precision-Optimized AAV Gene Therapy for SMAChunjuan Song, Jingbo Liu, Qingzeng Wang, et al.
Vaccine|October 17, 2022
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationTingting Deng, Tingting Li, Gege Chen, et al.
JCI Insight|May 22, 2019
Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunityYuanyuan Xiao, Manish Muhuri, Shaoyong Li, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Intravenous Administration of EXG110 Resulted in Substrate Correction in Fabry Mice and Sustained Enzyme Activity in Non-human PrimatesShaoyong Li, Pengfei Yu, Hong Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Challenging the More-Is-Better Dogma: A Precision-Optimized AAV Gene Therapy for SMAChunjuan Song, Jingbo Liu, Qingzeng Wang, et al.
Vaccine|October 17, 2022
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationTingting Deng, Tingting Li, Gege Chen, et al.
JCI Insight|May 22, 2019
Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunityYuanyuan Xiao, Manish Muhuri, Shaoyong Li, et al.
Pageof 4